These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 22934705

  • 1. Upregulation of focal adhesion kinase by 14-3-3ε via NFκB activation in hepatocellular carcinoma.
    Ko BS, Jan YJ, Chang TC, Liang SM, Chen SC, Liu TA, Wu YM, Wang J, Liou JY.
    Anticancer Agents Med Chem; 2013 May; 13(4):555-62. PubMed ID: 22934705
    [Abstract] [Full Text] [Related]

  • 2. Bortezomib suppresses focal adhesion kinase expression via interrupting nuclear factor-kappa B.
    Ko BS, Chang TC, Chen CH, Liu CC, Kuo CC, Hsu C, Shen YC, Shen TL, Golubovskaya VM, Chang CC, Shyue SK, Liou JY.
    Life Sci; 2010 Jan 30; 86(5-6):199-206. PubMed ID: 20006625
    [Abstract] [Full Text] [Related]

  • 3. Focal adhesion kinase as a therapeutic target of bortezomib.
    Ko BS, Chang TC, Liou JY.
    Anticancer Agents Med Chem; 2010 Dec 30; 10(10):747-52. PubMed ID: 21269258
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells.
    Chen KF, Yeh PY, Yeh KH, Lu YS, Huang SY, Cheng AL.
    Cancer Res; 2008 Aug 15; 68(16):6698-707. PubMed ID: 18701494
    [Abstract] [Full Text] [Related]

  • 8. [Focal adhesion kinase mRNA overexpression in hepatocellular carcinoma HCC) and correlation thereof with prognosis of HCC].
    Yuan Z, Fan J, Wu ZQ, Zhou J, Qiu SJ.
    Zhonghua Yi Xue Za Zhi; 2007 May 15; 87(18):1256-9. PubMed ID: 17686260
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. CADM2, as a new target of miR-10b, promotes tumor metastasis through FAK/AKT pathway in hepatocellular carcinoma.
    Li D, Zhang Y, Zhang H, Zhan C, Li X, Ba T, Qiu Z, E F, Lv G, Zou C, Wang C, Si L, Zou C, Li Q, Gao X.
    J Exp Clin Cancer Res; 2018 Mar 05; 37(1):46. PubMed ID: 29506532
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prostaglandin E₂ receptor EP1-mediated phosphorylation of focal adhesion kinase enhances cell adhesion and migration in hepatocellular carcinoma cells.
    Bai X, Wang J, Zhang L, Ma J, Zhang H, Xia S, Zhang M, Ma X, Guo Y, Rong R, Cheng S, Shu W, Wang Y, Leng J.
    Int J Oncol; 2013 May 05; 42(5):1833-41. PubMed ID: 23525457
    [Abstract] [Full Text] [Related]

  • 13. Overexpressed focal adhesion kinase predicts a higher incidence of extrahepatic metastasis and worse survival in hepatocellular carcinoma.
    Jan YJ, Ko BS, Hsu C, Chang TC, Chen SC, Wang J, Liou JY.
    Hum Pathol; 2009 Oct 05; 40(10):1384-90. PubMed ID: 19454363
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Role of expression of focal adhesion kinase in progression of hepatocellular carcinoma.
    Itoh S, Maeda T, Shimada M, Aishima S, Shirabe K, Tanaka S, Maehara Y.
    Clin Cancer Res; 2004 Apr 15; 10(8):2812-7. PubMed ID: 15102689
    [Abstract] [Full Text] [Related]

  • 16. Focal adhesion kinase activation limits efficacy of Dasatinib in c-Myc driven hepatocellular carcinoma.
    Liu X, Song X, Zhang J, Xu Z, Che L, Qiao Y, Ortiz Pedraza Y, Cigliano A, Pascale RM, Calvisi DF, Liu Y, Chen X.
    Cancer Med; 2018 Dec 15; 7(12):6170-6181. PubMed ID: 30370649
    [Abstract] [Full Text] [Related]

  • 17. Quantitative proteomic dissection of a native 14-3-3ε interacting protein complex associated with hepatocellular carcinoma.
    Bai C, Tang S, Bai C, Chen X.
    Amino Acids; 2014 Apr 15; 46(4):841-52. PubMed ID: 24363202
    [Abstract] [Full Text] [Related]

  • 18. Expression of Src and FAK in hepatocellular carcinoma and the effect of Src inhibitors on hepatocellular carcinoma in vitro.
    Lau GM, Lau GM, Yu GL, Gelman IH, Gutowski A, Hangauer D, Fang JW.
    Dig Dis Sci; 2009 Jul 15; 54(7):1465-74. PubMed ID: 18979199
    [Abstract] [Full Text] [Related]

  • 19. Focal adhesion kinase confers lenvatinib resistance in hepatocellular carcinoma via the regulation of lysine-deficient kinase 1.
    Hou W, Gad SA, Ding X, Dhanarajan A, Qiu W.
    Mol Carcinog; 2024 Jan 15; 63(1):173-189. PubMed ID: 37787401
    [Abstract] [Full Text] [Related]

  • 20. 14-3-3ε mediates the cell fate decision-making pathways in response of hepatocellular carcinoma to Bleomycin-induced DNA damage.
    Tang S, Bao H, Zhang Y, Yao J, Yang P, Chen X.
    PLoS One; 2013 Jan 15; 8(3):e55268. PubMed ID: 23472066
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.